Technology | 2021.04.26
Addressing Immunogenicity Challenges to Select the Best Drug Development Candidate, Upcoming Webinar Hosted by Xtalks
In this free webinar, the featured speakers will discuss some of the approaches to therapeutic protein immunogenicity risk assessment including the use of in silico tools and different in vitro assays to mitigate risk and design drugs with a better chance of success in the clinic. Through case studies, they will illustrate complementary approaches that can be applied to different classes of proteins, and discuss the application of early design and developability technology to increase the chances of candidate success.
(PRWeb April 26, 2021)
Read the full story at https://www.prweb.com/releases/addressing_immunogenicity_challenges_to_select_the_best_drug_development_candidate_upcoming_webinar_hosted_by_xtalks/prweb17890464.htm
For more information, please visit
https://www.prweb.com/releases/addressin[...]ed_by_xtalks/prweb17890464.htm
